Abstract
This comprehensive overview explores sociocultural challenges in healthy eating and weight management, focusing on pharmacological interventions and psychotherapeutic options for care. The article evaluates the efficacy and safety of amphetamines, GLP-1 receptor agonists, and lipase blockers for weight loss. The emergence of GLP-1 agonists, such as liraglutide, semaglutide, and tirzepatide, is examined, emphasizing their potential benefits and drawbacks. The discussion delves into the complexities of weight loss pharmacology, considering societal influences, individual factors, and the importance of sustained behavioral changes. The vignette of Taylor’s journey further underscores the need for a holistic approach, integrating psychological, behavioral, and environmental aspects for long-term weight management success.
Continuing education course available on CE.NationalRegister.org
The National Register of Health Service Psychologists is approved by the American Psychological Association to sponsor continuing education for psychologists. The National Register maintains responsibility for this program and its content.
The National Register of Health Service Psychologists is recognized by the New York State Education Department’s State Board for Psychology as an approved provider of continuing education for licensed psychologists #PSY-0010
English
Español
Deutsch
Français
Italiano
Português
العربية
简体中文
Русский